Cellular prion protein mediates impairment of synaptic plasticity by amyloid-Β oligomers

Nature

Volumn 457, Issue 7233, 2009, Pages 1128-1132

  Laurén, Juha ^a   Gimbel, David A ^a   Nygaard, Haakon B ^a   Gilbert, John W ^a   Strittmatter, Stephen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA OLIGOMER; AMYLOID BETA PROTEIN; ANTICELLULAR PRION PROTEIN ANTIBODY; CELLULAR PRION PROTEIN; OLIGOMER; PRION PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

BRAIN; CELL ORGANELLE; CLONE; CONCENTRATION (COMPOSITION); DISEASE; PATHOLOGY; PROTEIN; RODENT;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CLONING; CONTROLLED STUDY; HIPPOCAMPUS; LONG TERM POTENTIATION; NERVE BLOCK; NERVE CELL PLASTICITY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; AMYLOIDOSIS; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MICE; MICE, INBRED C57BL; NEURONAL PLASTICITY; NEURONS; PEPTIDE FRAGMENTS; PRIONS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECEPTORS, CELL SURFACE; SYNAPSES;

MUS; MUS MUSCULUS; RODENTIA;

EID: 61349201380     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature07761     Document Type: Article

References (37)

1. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
2. Lesne, S. et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357 (2006).
3. Cleary, J. P. et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nature Neurosci. 8, 79-84 (2005).
4. 1-42 into globular neurotoxins. Biochemistry 42, 12749-12760 (2003).
5. Lacor, P. N. et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 27, 796-807 (2007).
6. Lacor, P. N. et al. Synaptic targeting by Alzheimer's-related amyloid β oligomers. J. Neurosci. 24, 10191-10200 (2004).
7. Walsh, D. M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539 (2002).
8. Shankar, G. M. et al. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27, 2866-2875 (2007).
9. Shankar, G. M. et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Med. 14, 837-842 (2008).
10. Hepler, R. W. et al. Solution state characterization of amyloid β-derived diffusible ligands. Biochemistry 45, 15157-15167 (2006).
11. 1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448-6453 (1998).
12. Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363-13383 (1998).
13. Yan, S. D. et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (1996).
14. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275, 5626-5632 (2000).
15. Viles, J. H. et al. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl Acad. Sci. USA 96, 2042-2047 (1999).
16. Jackson, G. S. et al. Location and properties of metal-binding sites on the human prion protein. Proc. Natl Acad. Sci. USA 98, 8531-8535 (2001).
17. Baumann, F. et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 26, 538-547 (2007).
18. Li, A. et al. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J. 26, 548-558 (2007).
19. Riek, R. et al. NMR structure of the mouse prion protein domain PrP(121-321). Nature 382, 180-182 (1996).
20. Bueler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582 (1992).
21. Manson, J. C. et al. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8, 121-127 (1994).
22. Lledo, P. M., Tremblay, P., DeArmond, S. J., Prusiner, S. B. & Nicoll, R. A. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc. Natl Acad. Sci. USA 93, 2403-2407 (1996).
23. Curtis, J., Errington, M., Bliss, T., Voss, K. & MacLeod, N. Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol. Dis. 13, 55-62 (2003).
24. Riemenschneider, M. et al. Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 63, 364-366 (2004).
25. Papassotiropoulos, A. et al. The prion gene is associated with human long-term memory. Hum. Mol. Genet. 14, 2241-2246 (2005).
26. Yehiely, F. et al. Identification of candidate proteins binding to prion protein. Neurobiol. Dis. 3, 339-355 (1997).
27. Schmitt-Ulms, G. et al. Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nature Biotechnol. 22, 724-731 (2004).
28. Venkitaramani, D. V. et al. β-amyloid modulation of synaptic transmission and plasticity. J. Neurosci. 27, 11832-11837 (2007).
29. Hsieh, H. et al. AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843 (2006).
30. Khosravani, H. et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol. 181, 551-565 (2008).
31. Folta-Stogniew, E. Oligomeric states of proteins determined by size-exclusion chromatography coupled with light scattering, absorbance, and refractive index detectors. Methods Mol. Biol. 328, 97-112 (2006).
32. Rajagopalan, S. et al. Neogenin mediates the action of repulsive guidance molecule. Nature Cell Biol. 6, 756-762 (2004).
33. Fournier, A. E., GrandPre, T. & Strittmatter, S. M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409, 341-346 (2001).
34. Takahashi, T. et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99, 59-69 (1999).
35. Takahashi, T., Nakamura, F., Jin, Z., Kalb, R. G. & Strittmatter, S. M. Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors. Nature Neurosci. 1, 487-493 (1998).
36. Weissmann, C. & Flechsig, E. PrP knock-out and PrP transgenic mice in prion research. Br. Med. Bull. 66, 43-60 (2003).
37. Chen, S., Mange, A., Dong, L., Lehmann, S. & Schachner, M. Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol. Cell. Neurosci. 22, 227-233 (2003).